אוקסליפלטין PWD טבע ®
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
OXALIPLATIN 100 MG/VIAL
Available from:
SALOMON,LEVIN & ELSTEIN LTD
ATC code:
L01XA03
Pharmaceutical form:
POWDER FOR SOLUTION FOR INFUSION
Administration route:
I.V
Manufactured by:
PHARMACHEMIE BV, HOLLAND (TEVA GROUP)
Therapeutic group:
OXALIPLATIN
Therapeutic indications:
Oxaliplatin in combination with 5- fluorouracil (5-FU) and folinic acid (FA) is indicated for : - Adjuvant treatment of stage III (Duke's C) colon cancer after complete resection of the primary tumour. - Treatment of metastatic colorectal cancer.
Authorization date:
2010-01-01
